Results 81 to 90 of about 7,157,255 (226)

Prediction of Drug–Target Binding Kinetics by Comparative Binding Energy Analysis

open access: yes, 2018
A growing consensus is emerging that optimizing the drug–target affinity alone under equilibrium conditions does not necessarily translate into higher potency in vivo and that instead binding kinetic parameters should be optimized to ensure better ...
Rebecca C. Wade (170810)   +1 more
core   +3 more sources

AFIR: A Dimensionless Potency Metric for Characterizing the Activity of Monoclonal Antibodies

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2017
For monoclonal antibody (mAb) drugs, soluble targets may accumulate several thousand fold after binding to the drug. Time course data of mAb and total target is often collected and, although free target is more closely related to clinical effect, it is ...
AM Stein, R Ramakrishna
doaj   +1 more source

Dipeptide Frequency of Word Frequency and Graph Convolutional Networks for DTA Prediction

open access: yesFrontiers in Bioengineering and Biotechnology, 2020
Deep learning is an effective method to capture drug-target binding affinity, but low accuracy is still an obstacle to be overcome. Thus, we propose a novel predictor for drug-target binding affinity based on dipeptide frequency of word frequency ...
Xianfang Wang   +6 more
doaj   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Drug target binding affinity prediction considering the interaction of molecule atom and protein subsequences

open access: yes, 2021
The identification of drug target interactions is an important task in drug discovery. To model the interaction of drug and protein, most of the computational methods of drug target affinity prediction have been proposed the global interaction between ...
Haelee Bae
core   +1 more source

DTBind: A Mechanism-Driven Deep Learning Framework for Accurate Prediction of Drug–Target Molecular Recognition

open access: yesResearch
Accurate prediction of drug–target molecular recognition is essential for early-stage drug discovery, spanning binding occurrence, binding site localization, and binding affinity estimation.
Qiuyu Li   +8 more
doaj   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy

open access: yesMolecular Oncology, EarlyView.
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley   +1 more source

Binding Affinity Prediction with 3D Machine Learning: Training Data and Challenging External Testing [PDF]

open access: yes
Protein-ligand binding affinity prediction is one of the major challenges in computational assisted drug discovery. An active area of research uses machine learning (ML) models trained on 3D structures of protein ligand complexes to predict binding modes,
Gary , Tresadern   +3 more
core   +2 more sources

DrugForm-TAS: Target-Agnostic Selectivity as Proteome-wide Binding Propensity Estimation

open access: yesComputational and Structural Biotechnology Journal
Assessing the selectivity of binding a small molecule with proteins remains a fundamental yet unresolved challenge in computational drug discovery. Conventional strategies for estimating ligand selectivity depend on exhaustive cross-prediction of binding
Anna Tashchilova   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy